Home › Biblio

Biblio

Found 7 results

2011
van Zijl F, Mall S, Machat G, Pirker C, Zeillinger R, Weinhaeusel A, Bilban M, Berger W, Mikulits W.  2011.  A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression.. Molecular cancer therapeutics. 10(5):850-60. Abstract
van Zijl F, Krupitza G, Mikulits W.  2011.  Initial steps of metastasis: cell invasion and endothelial transmigration.. Mutation research. 728(1-2):23-34. Abstract
Schneller D, Machat G, Sousek A, Proell V, van Zijl F, Zulehner G, Huber H, Mair M, Muellner MK, Nijman SMB et al..  2011.  p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.. Hepatology (Baltimore, Md.). 54(1):164-72. Abstract
2010
van Zijl F, Mikulits W.  2010.  Hepatospheres: Three dimensional cell cultures resemble physiological conditions of the liver.. World journal of hepatology. 2(1):1-7. Abstract
Zulehner G, Mikula M, Schneller D, van Zijl F, Huber H, Sieghart W, Grasl-Kraupp B, Waldhör T, Peck-Radosavljevic M, Beug H et al..  2010.  Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.. The American journal of pathology. 176(1):472-81. Abstract
Blaas L, Kornfeld J-W, Schramek D, Musteanu M, Zollner G, Gumhold J, van Zijl F, Schneller D, Esterbauer H, Egger G et al..  2010.  Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis.. Hepatology (Baltimore, Md.). 51(4):1319-26. Abstract
2009
van Zijl F, Zulehner G, Petz M, Schneller D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H, Mikulits W.  2009.  Epithelial-mesenchymal transition in hepatocellular carcinoma.. Future oncology (London, England). 5(8):1169-79. Abstract

Your Support is the Key

Submitted by admin on May 9, 2011 - 11:20am

Matthew Slattery

Help children like Matthew unlock their potential by becoming a Partner in Potential.

Donate Learn More